A generic image of two people sitting across from each other
Markets

After-Hours Earnings Report for March 12, 2018 : KRO, COUP, TTEC, IOVA, AMPH, REN, KURA, VNET, AKBA, TRHC, AVD, IRET

The following companies are expected to report earnings after hours on 03/12/2018. Visit our Earnings Calendar for a full list of expected earnings releases.

Kronos Worldwide Inc ( KRO ) is reporting for the quarter ending December 31, 2017. The chemical company's consensus earnings per share forecast from the 1 analyst that follows the stock is $0.49. This value represents a 206.25% increase compared to the same quarter last year. KRO missed the consensus earnings per share in the 2nd calendar quarter of 2017 by -19.05%. Zacks Investment Research reports that the 2017 Price to Earnings ratio for KRO is 14.65 vs. an industry ratio of 14.90.

Coupa Software Incorporated ( COUP ) is reporting for the quarter ending January 31, 2018. The internet software company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.30. This value represents a 150.00% decrease compared to the same quarter last year. In the past year COUP has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 24%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for COUP is -51.48 vs. an industry ratio of 19.70.

TTEC Holdings, Inc. ( TTEC ) is reporting for the quarter ending December 31, 2017. The outsourcing company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.60. This value represents a 42.86% increase compared to the same quarter last year. Zacks Investment Research reports that the 2017 Price to Earnings ratio for TTEC is 21.03 vs. an industry ratio of 30.30.

Iovance Biotherapeutics, Inc. ( IOVA ) is reporting for the quarter ending December 31, 2017. The biomedical (gene) company's consensus earnings per share forecast from the 6 analysts that follow the stock is $-0.32. This value represents a 28.00% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2017 Price to Earnings ratio for IOVA is -14.15 vs. an industry ratio of -7.10.

Amphastar Pharmaceuticals, Inc. ( AMPH ) is reporting for the quarter ending December 31, 2017. The medical company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.04. This value represents a 33.33% increase compared to the same quarter last year. AMPH missed the consensus earnings per share in the 1st calendar quarter of 2017 by -50%. Zacks Investment Research reports that the 2017 Price to Earnings ratio for AMPH is -478.50 vs. an industry ratio of -22.20.

Resolute Energy Corporation ( REN ) is reporting for the quarter ending December 31, 2017. The oil (us exp & production) company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.62. This value represents a 179.49% increase compared to the same quarter last year. Zacks Investment Research reports that the 2017 Price to Earnings ratio for REN is 41.92 vs. an industry ratio of 32.90, implying that they will have a higher earnings growth than their competitors in the same industry.

Kura Oncology, Inc. ( KURA ) is reporting for the quarter ending December 31, 2017. The biomedical (gene) company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.34. This value represents a 10.53% increase compared to the same quarter last year. KURA missed the consensus earnings per share in the 3rd calendar quarter of 2017 by -2.7%. Zacks Investment Research reports that the 2017 Price to Earnings ratio for KURA is -15.27 vs. an industry ratio of -7.10.

21Vianet Group, Inc. ( VNET ) is reporting for the quarter ending December 31, 2017. The internet services company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.12. This value represents a 14.29% increase compared to the same quarter last year. Zacks Investment Research reports that the 2017 Price to Earnings ratio for VNET is -17.60 vs. an industry ratio of 12.70.

Akebia Therapeutics, Inc. ( AKBA ) is reporting for the quarter ending December 31, 2017. The drug company's consensus earnings per share forecast from the 2 analysts that follow the stock is $-0.18. This value represents a 81.82% increase compared to the same quarter last year. The "days to cover" for this stock exceeds 10 days. Zacks Investment Research reports that the 2017 Price to Earnings ratio for AKBA is -6.26 vs. an industry ratio of -8.30, implying that they will have a higher earnings growth than their competitors in the same industry.

Tabula Rasa HealthCare, Inc. ( TRHC ) is reporting for the quarter ending December 31, 2017. The medical information systems company's consensus earnings per share forecast from the 4 analysts that follow the stock is $0.12. This value represents a 300.00% increase compared to the same quarter last year. Zacks Investment Research reports that the 2017 Price to Earnings ratio for TRHC is 1218.00 vs. an industry ratio of 96.10, implying that they will have a higher earnings growth than their competitors in the same industry.

American Vanguard Corporation ( AVD ) is reporting for the quarter ending December 31, 2017. The chemical company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.17. This value represents a 30.77% increase compared to the same quarter last year. AVD missed the consensus earnings per share in the 3rd calendar quarter of 2017 by -17.65%. Zacks Investment Research reports that the 2017 Price to Earnings ratio for AVD is 35.00 vs. an industry ratio of 22.40, implying that they will have a higher earnings growth than their competitors in the same industry.

Investors Real Estate Trust ( IRET ) is reporting for the quarter ending January 31, 2018. The reit company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.10. This value represents a 16.67% decrease compared to the same quarter last year. IRET missed the consensus earnings per share in the 1st calendar quarter of 2017 by -7.69%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for IRET is 13.17 vs. an industry ratio of 15.70.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AVD KURA COUP VNET TTEC IOVA AKBA TRHC AMPH KRO IRET

Other Topics

Earnings